Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
Browsing: Viral > Hepatitis
Take a look behind the scenes of a recent Future Virology review, entitled: ‘Comparative host genomics: Has recent human evolution affected our immune defense against hepatitis C virus?’, as we ask the authors about the importance of the IFNL4 gene and the work that’s still to be done in the field.
Take a look behind the scenes of a recent Future Virology review entitled ‘An update on the management of hepatitis C virus and human immunodeficiency virus coinfection’, as we ask the authors about their inspiration and the future of this field.
The largest population study of hepatitis C in Africa has discovered three new strains of the virus with unknown susceptibility to currently used antiviral treatments.
During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Take a look at how portable, long-read nanopore sequencing can be applied to the study of hepatitis B virus.
Take a look behind the scenes of a recent Future Virology review as we ask author Geoffrey Dusheiko about the challenges facing hepatitis B and what the future may hold in terms of functional cure and new research directions.